SKI Market

A+| A| A-|

Indian Indices

Sensex

79,273.33 753.03
( 0.96%)

Global Indices

Nasdaq

49,464.98 -3.46
(-0.01%)

Dow Jones

7,130.75 -16.31
(-0.23%)

Hang Seng

59,361.39 536.50
(0.91%)

Nikkei 225

10,604.22 -63.41
(-0.59%)

Forex

USD-INR

92.58 -0.61
(-0.65%)

EUR-INR

108.87 -0.98
(-0.89%)

GBP-INR

125.07 -1.17
(-0.93%)

JPY-INR

0.58 0.00
(-0.45%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

17.34

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

246.67

56.43

EPS(TTM)

Face Value()

Div & Yield %

0.15

Back

Bajaj Finance consolidated net profit declines 6.33% in the December 2025 quarter

Feb 04,2026

Net profit of Bajaj Finance declined 6.33% to Rs 3977.85 crore in the quarter ended December 2025 as against Rs 4246.54 crore during the previous quarter ended December 2024. Sales rose 18.44% to Rs 20884.03 crore in the quarter ended December 2025 as against Rs 17632.98 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	20884.03	17632.98	18
OPM %	63.57	70.00	-
PBDT	5940.23	5984.55	-1
PBT	5696.32	5765.42	-1
NP	3977.85	4246.54	-6

79,273.33 753.03 ( 0.96%)

49,464.98 -3.46 (-0.01%)

7,130.75 -16.31 (-0.23%)

59,361.39 536.50 (0.91%)

10,604.22 -63.41 (-0.59%)

92.58 -0.61 (-0.65%)

108.87 -0.98 (-0.89%)

125.07 -1.17 (-0.93%)

0.58 0.00 (-0.45%)